User profiles for Farhat Khanim
Farhat KhanimUniversity of Birmingham Verified email at bham.ac.uk Cited by 3539 |
[PDF][PDF] Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1
C Hardy, F Khanim, R Torres, M Scott-Brown… - The American Journal of …, 1999 - cell.com
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by
juvenile-onset diabetes mellitus and progressive optic atrophy. mtDNA deletions have been …
juvenile-onset diabetes mellitus and progressive optic atrophy. mtDNA deletions have been …
WFS1/wolframin mutations, Wolfram syndrome, and associated diseases
Wolfram syndrome (WS) is the inherited association of juvenile‐onset insulin‐dependant
diabetes mellitus and progressive bilateral optic atrophy. A nuclear gene, WFS1/wolframin, was …
diabetes mellitus and progressive bilateral optic atrophy. A nuclear gene, WFS1/wolframin, was …
Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations
F Khanim, QY Yao, G Niedobitek, S Sihota… - 1996 - ashpublications.org
While Epstein-Barr virus (EBV) infection is associated with the development of certain
lymphoid and epithelial tumors, the role of the virus in the pathogenesis of these malignancies …
lymphoid and epithelial tumors, the role of the virus in the pathogenesis of these malignancies …
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC
Ingenol 3-angelate (PEP005) is a selective small molecule activator of protein kinase C (PKC)
extracted from the plant Euphorbia peplus, whose sap has been used as a traditional …
extracted from the plant Euphorbia peplus, whose sap has been used as a traditional …
[HTML][HTML] Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines
Combined bezafibrate (BEZ) and medroxyprogesterone acetate (MPA) exert unexpected
antileukaemic activities against acute myeloid leukaemia (AML) and these activities are …
antileukaemic activities against acute myeloid leukaemia (AML) and these activities are …
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells
FL Khanim, LM Gommersall, VHJ Wood, KL Smith… - Oncogene, 2004 - nature.com
We hypothesized that key antiproliferative target genes for the vitamin D receptor (VDR)
were repressed by an epigenetic mechanism in prostate cancer cells resulting in apparent …
were repressed by an epigenetic mechanism in prostate cancer cells resulting in apparent …
[HTML][HTML] Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes
FE Turner, S Broad, FL Khanim, A Jeanes… - Journal of biological …, 2006 - ASBMB
The human epidermis is a self-renewing epithelial tissue composed of several layers of
keratinocytes. Within the epidermis there exists a complex array of cell adhesion structures, and …
keratinocytes. Within the epidermis there exists a complex array of cell adhesion structures, and …
The aldo-keto reductase AKR1C3 contributes to 7, 12-dimethylbenz (a) anthracene-3, 4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for …
The aldo-keto reductase AKR1C3, has been shown to regulate myelopoiesis via its ability to
metabolise prostaglandin D 2 (PGD 2 ). Other studies have demonstrated the oxidative …
metabolise prostaglandin D 2 (PGD 2 ). Other studies have demonstrated the oxidative …
[HTML][HTML] The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models
…, Z Yang, E Vicenzi, MA Skidmore, FL Khanim… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has caused
a significant number of fatalities and worldwide disruption. To identify drugs to repurpose to …
a significant number of fatalities and worldwide disruption. To identify drugs to repurpose to …
Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
The redeployed drug combination of bezafibrate and medroxyprogesterone acetate (designated
BaP) has potent in vivo anticancer activity in acute myelogenous leukemia (AML) and …
BaP) has potent in vivo anticancer activity in acute myelogenous leukemia (AML) and …